Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00918762 · ClinicalTrials.gov registry record · Phase 1

Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx

A Phase 1 study, sponsored by Barbara Ann Karmanos Cancer Institute.

Completed
Registry status
Phase 1
Development phase
6
Enrollment target

NCT00918762: Completed Phase 1 study, sponsored by Barbara Ann Karmanos Cancer Institute.

NCT00918762 is a Phase 1 study that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00918762, a Phase 1 study, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.

COMPLETED
Registry status
Phase 1
Development phase
6 participants
Enrollment target

Study Summary

RATIONALE: Transoral robotic surgery may make it easier to find and remove benign or malignant tumors of the larynx and pharynx and cause less damage to normal tissue. It is not yet known whether transoral robotic surgery is more effective than standard surgery in diagnosing and treating larynx and pharynx tumors. PURPOSE: This phase I trial is studying how well transoral robotic surgery works compared with standard surgery in treating patients with benign or malignant tumors of the larynx or pharynx.

Interventions

  • PROCEDURE therapeutic conventional surgery
  • PROCEDURE quality-of-life assessment
  • PROCEDURE assessment of therapy complications
  • PROCEDURE diagnostic endoscopic surgery
  • PROCEDURE therapeutic endoscopic surgery

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2009-05
Est. Completion 2010-10
Phase Phase 1

What the finished NCT00918762 record still lists

NCT00918762 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 5 interventions - of which therapeutic conventional surgery is the first listed.

NCT00918762 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00918762 about?

NCT00918762 is a clinical study titled "Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx". RATIONALE: Transoral robotic surgery may make it easier to find and remove benign or malignant tumors of the larynx and pharynx and cause less damage to normal tissue. It is not yet known whether transoral robotic surgery is more effective than standard surgery in diagnosing and treating larynx and ...

What is the current status of trial NCT00918762?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2009-05. Estimated completion is 2010-10.

What interventions are being tested in trial NCT00918762?

The interventions under investigation include: therapeutic conventional surgery (PROCEDURE), quality-of-life assessment (PROCEDURE), assessment of therapy complications (PROCEDURE), diagnostic endoscopic surgery (PROCEDURE), therapeutic endoscopic surgery (PROCEDURE).

Who is sponsoring clinical trial NCT00918762?

This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00918762's enrollment target sits among peer trials

6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00918762, the US trial registry maintained by the National Library of Medicine. NCT00918762 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.